Barclays Calls Valeant Its Top
Pick Moneybeat Wsj
Summary | Shares of Valeant Pharmaceuticals International Inc.
are up more than 60% this year, and Barclays PLC analyst Doug
Tsao expects the pharmaceutical company's stock can keep
climbing.
blogs.wsj.com | 30 April 2015